Australia markets close in 1 hour 28 minutes

Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
24.78-0.07 (-0.28%)
As of 11:29AM CST. Market open.

Henan Lingrui Pharmaceutical Co., Ltd.

No.666 Jiangjun Road
Xin County
Xinyang 465550
China
86 37 6298 8888
https://www.lingrui.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Wei XiongGM & DirectorN/AN/A1986
Mr. Peng YuChief Financial OfficerN/AN/A1969
Mr. Xi Zhen WuDeputy GM & DirectorN/AN/A1965
Ms. Yan ChenDeputy GM & DirectorN/AN/A1972
Mr. Guo Xin FengSecretary of the Board & DirectorN/AN/A1990
Mr. Hui Bin WuDeputy General ManagerN/AN/A1974
Mr. Qiang YeDeputy General ManagerN/AN/A1972
Mr. Lei LiDeputy General ManagerN/AN/A1983
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering various product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is based in Xinyang, China.

Corporate governance

Henan Lingrui Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.